Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Mucopolysaccharidosis VII Disease Monitoring Program (MPS VII DMP)

Trial Profile

Mucopolysaccharidosis VII Disease Monitoring Program (MPS VII DMP)

Status: Recruiting
Phase of Trial: Phase IV

Latest Information Update: 26 Sep 2024

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Vestronidase alfa (Primary)
  • Indications Mucopolysaccharidosis VII
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms MPS VII DMP
  • Sponsors Ultragenyx Pharmaceutical

Most Recent Events

  • 10 Oct 2022 Planned number of patients changed from 35 to 50.
  • 09 Jul 2020 Status changed from active, no longer recruiting to recruiting.
  • 30 Mar 2020 Status changed from recruiting to active, no longer recruiting.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top